Sign in

CIK 0001650648

  • Non-accelerated filer
  • Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473506994
Phone
+1 510-505-2680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,616,428
in 5 filings, $1.6M under 10b5-1 plans

Net −$1,616,428. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-05-15 Moretti August J Chief Financial Officer Exercise or conversion +3,000 $9.41 $28K 11,045
2023-05-15 Moretti August J Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −3,000 217,060
2023-02-10 Moretti August J Chief Financial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-12-21 Moretti August J Chief Financial Officer Exercise or conversion +3,000 $9.41 $28K 6,595
2022-12-21 Moretti August J Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −3,000 220,060
2022-09-01 Moretti August J Chief Financial Officer Grant or award · Stock Option (Right to Buy) −60,000 60,000
2022-02-01 Moretti August J Chief Financial Officer Grant or award · Stock Option (Right to Buy) −65,000 65,000
2021-04-12 Moretti August J Chief Financial Officer Exercise or conversion +1,000 $9.41 $9K 2,000
2021-04-12 Moretti August J Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −1,000 223,060
2021-03-08 Moretti August J Grant or award · Stock Option (Right to Buy) +70,000 70,000

Page 1 of 1 · 10 trades